QUANTITATIVE BIOSCIENCES, INC.
San Diego, CA · Medtech · Private
Low-power modular biosensor platform for simultaneous detection of biological and chemical contaminants in water and food using genetically engineered biosensing strains
qbisci.com →- Grants
- $3.0M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $11M
- 7 awards · Defense, Environmental Prot, the Interior
- #67 of 4531 in medtech
- Patents
- 5
- 0 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2015201720192021202320252027
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense · Igf::ot::igf Compact Microfluidic Biosensor | $3,000,000 | |
| Federal contract | Department of Defense · Ffp Milestone Contract For Bto Study Entitled An Electrical Impedance Platform For Interfacing Synthetic Biology With Microelectronics | $2,724,573 | |
| Federal grant | Department of Health and Human Services · Phase I · A Customizable Real-Time Biosensor for Continuous Monitoring of Water Contaminants | $162,205 | |
| Federal grant | Department of Defense · Phase II · Modular, low-power, and compact sensor for detecting chemical and biological contaminants in water and food | $2,000,000 | |
| Federal grant | Department of Health and Human Services · Phase I · An Online, Real-Time Microfluidic Biosensor for PFOA and PFOS | $256,580 | |
| Federal contract | Environmental Protection Agency · Epa SBIR FY21-22 Phase I - A Smart-sensor Approach To Automating And Optimizing Agricultural Water Reuse | $100,000 | |
| Federal grant | Department of Agriculture · Pesticides Are Among The Most Ubiquitous And Persistent Contaminants, And Human Epidemiological Studies Have Found Associations Between Pesticide Exposure And A Number Of Adverse Health Conditions. We Will Develop A Nanobody-based Biosensor Strain Along With A On-line Biosensor Platform That Uses A Microfluidic Device To Detect And Quantify The Pesticide Chlorpyrifos In Real Time.objective 1: To Identify And Characterize The Binding Kinetics Of Nanobodies For Chlorpyrifos. We Will Identify Nanob | $181,500 | |
| Federal contract | Department of Defense · A Sensitive, Multiplexed, And On-line Sensor For Target-agnostic Water Monitoring | $3,999,991 | |
| Federal grant | Department of Health and Human Services · Phase I · CLEdgeSeq: Advanced sequence analysis and communication for edge applications | $350,000 | |
| Federal contract | Department of Defense · Embedded Entrepreneurship Initiative (eei) | $315,000 | |
| Federal contract | Department of the Interior · Cell And Gene Therapy Process Analytical Technology And Quality Control Testing | $600,000 | |
| Federal contract | Department of Health and Human Services · Quantitative Biosciences, INC.:1311431 [26-003384] | $25,000 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 64 | TANGEN BIOSCIENCES, INC. | $11M | $20M |
| 65 | Countervail Corporation | $11M | — |
| 66 | BLACKROCK MICROSYSTEMS, INC | $11M | $12M |
| 67 | QUANTITATIVE BIOSCIENCES, INC. | $11M | — |
| 68 | Biomeme Inc | $11M | $5.5M |
| 69 | iWalk, Inc. | $10M | $57M |
| 70 | THE ULTRAN GROUP, INC. | $9.8M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Engineered Biosensor Strains Of E. Coli For Continuous Aerobic Detection Of Analytesapplication
- Fentanyl-specific Single Variable-domain Antibodies And Use In A Continuous Agglutination Assayapplication
- Engineered Biosensor Strains of E. Coli for Continuous Aerobic Detection of Analytesapplication
- Fentanyl-specific Single Variable-domain Antibodies And Use In A Continuous Agglutination Assayapplication
- Fentanyl-specific Single Variable-domain Antibodies And Use In A Continuous Agglutination Assayapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.